| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40032-950-01 | 40032-950 | HUMAN PRESCRIPTION DRUG | Oxycodone Hydrochloride | Oxycodone Hydrochloride | CAPSULE | ORAL | 20150824 | N/A | ANDA | ANDA204752 | Novel Laboratories, Inc. | OXYCODONE HYDROCHLORIDE | 5 mg/1 | 100 CAPSULE in 1 BOTTLE (40032-950-01) |
| 40032-950-03 | 40032-950 | HUMAN PRESCRIPTION DRUG | Oxycodone Hydrochloride | Oxycodone Hydrochloride | CAPSULE | ORAL | 20150824 | N/A | ANDA | ANDA204752 | Novel Laboratories, Inc. | OXYCODONE HYDROCHLORIDE | 5 mg/1 | 30 CAPSULE in 1 BOTTLE (40032-950-03) |
| 40032-950-50 | 40032-950 | HUMAN PRESCRIPTION DRUG | Oxycodone Hydrochloride | Oxycodone Hydrochloride | CAPSULE | ORAL | 20150824 | N/A | ANDA | ANDA204752 | Novel Laboratories, Inc. | OXYCODONE HYDROCHLORIDE | 5 mg/1 | 500 CAPSULE in 1 BOTTLE (40032-950-50) |